首页> 外文期刊>Anesthesiology >The Anesthesia in Abdominal Aortic Surgery (ABSENT) Study: A Prospective, Randomized, Controlled Trial Comparing Troponin T Release with Fentanyl-Sevoflurane and Propofol-Remifentanil Anesthesia in Major Vascular Surgery
【24h】

The Anesthesia in Abdominal Aortic Surgery (ABSENT) Study: A Prospective, Randomized, Controlled Trial Comparing Troponin T Release with Fentanyl-Sevoflurane and Propofol-Remifentanil Anesthesia in Major Vascular Surgery

机译:腹主动脉手术中的麻醉(ABSENT)研究:一项前瞻性,随机,对照试验,比较了在主要血管外科手术中肌钙蛋白T释放与芬太尼-戊氟醚和丙泊酚-瑞芬太尼麻醉的比较

获取原文
获取原文并翻译 | 示例
           

摘要

Background: On the basis of data indicating that volatile anes-thetics induce cardioprotection in cardiac surgery, current guidelines recommend volatile anesthetics for maintenance of general anesthesia during noncardiac surgery in hemodynamic stable patients at risk for perioperative myocardial ischemia. The aim of the current study was to compare increased troponin T (TnT) values in patients receiving sevoflurane-based anesthesia or total intravenous anesthesia in elective abdominal aortic surgery. Methods: A prospective, randomized, open, parallel-group trial comparing sevoflurane-based anesthesia (group S) and total intravenous anesthesia (group T) with regard to cardioprotection in 193 patients scheduled for elective abdominal aortic surgery. Increased TnT level on the first postoperative day was the primary endpoint. Secondary endpoints were postoperative complications, nonfatal coronary events and mortality. Results: On the first postoperative day increased TnT values (>13ng/l) were found in 43 (44%) patients in group S versus 41 (43%) in group T (P = 0.999), with no significant differences in TnT levels between the groups at any time point. Although underpowered, the authors found no differences in postoperative complications, nonfatal coronary events or mortality between the groups. Conclusions: In elective abdominal aortic surgery sevoflurane-based anesthesia did not reduce myocardial injury, evaluated by TnT release, compared with total intravenous anesthesia. These data indicate that potential cardioprotec-tive effects of volatile anesthetics found in cardiac surgery are less obvious in major vascular surgery.
机译:背景:根据表明挥发性麻醉剂可在心脏手术中诱导心脏保护的数据,目前的指南建议使用挥发性麻醉剂在血液动力学稳定且有围手术期心肌缺血风险的非心脏手术患者中维持全身麻醉。本研究的目的是比较选择性腹主动脉手术中接受七氟醚类麻醉或全静脉麻醉的患者肌钙蛋白T(TnT)值的增加。方法:一项前瞻性,随机,开放,平行分组的试验,比较了计划进行腹主动脉手术的193例患者中以七氟醚为基础的麻醉(S组)和全静脉麻醉(T组)在心脏保护方面的关系。术后第一天TnT水平升高是主要终点。次要终点是术后并发症,非致命性冠状动脉事件和死亡率。结果:术后第一天,S组中43例(44%)患者的TnT值升高(> 13ng / l),而T组中41例(43%)(P = 0.999),TnT水平无显着差异在任何时间点在组之间切换。尽管动力不足,但作者发现两组之间的术后并发症,非致命性冠脉事件或死亡率无差异。结论:在选择性腹主动脉手术中,与全静脉麻醉相比,以TnT释放评估的七氟醚为基础的麻醉并没有减轻心肌损伤。这些数据表明,在心脏手术中发现的挥发性麻醉药对心脏的潜在保护作用在大血管手术中不太明显。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号